BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 28671806)

  • 1. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF; Hollenberg SM
    FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic and bleeding complications of prosthetic heart valves.
    Edmunds LH
    Ann Thorac Surg; 1987 Oct; 44(4):430-45. PubMed ID: 3310938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of artificial heart valve replacement in infants and children.
    Tong E
    J Cardiovasc Nurs; 1992 Apr; 6(3):30-43. PubMed ID: 1556584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
    Chesebro JH; Adams PC; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of prosthetic heart valves for adult patients by age].
    Hashimoto K
    Nihon Geka Gakkai Zasshi; 2007 Mar; 108(2):69-72. PubMed ID: 17405540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postoperative anticoagulation after mechanical valve replacement: a systematic review.
    Kulik A; Rubens FD; Wells PS; Kearon C; Mesana TG; van Berkom J; Lam BK
    Ann Thorac Surg; 2006 Feb; 81(2):770-81. PubMed ID: 16427905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
    Bian C; Qi X; Li L; Zhao J; Liu X
    Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation.
    Carnicelli AP; O'Gara PT; Giugliano RP
    Am J Cardiol; 2016 Nov; 118(9):1419-1426. PubMed ID: 27666180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant management of pregnancy following heart valve replacement in the United Kingdom, 1986-2002.
    Shannon MS; Edwards MB; Long F; Taylor KM; Bagger JP; De Swiet M
    J Heart Valve Dis; 2008 Sep; 17(5):526-32. PubMed ID: 18980086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option.
    McLintock C
    Thromb Res; 2011 Feb; 127 Suppl 3():S56-60. PubMed ID: 21262443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment associated with heart valve replacement.
    Coulshed DS; Fitzpatrick MA; Lee CH
    Drugs; 1995 Jun; 49(6):897-911. PubMed ID: 7641604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anticoagulation regimens for pregnant women with prosthetic heart valves: A meta-analysis of prospective studies.
    Wang J; Li K; Li H; Zhu W; Sun H; Lu C
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28799251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
    Vaughan P; Waterworth PD
    J Heart Valve Dis; 2005 Sep; 14(5):576-82. PubMed ID: 16245494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.
    Gajanana D; Rogers T; Weintraub WS; Iantorno M; Buchanan KD; Ben-Dor I; Pichard AD; Satler LF; Thourani VH; Torguson R; Okubagzi PG; Waksman R
    Am J Cardiol; 2018 Nov; 122(9):1536-1540. PubMed ID: 30180957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular heart disease in pregnancy: a review of the literature.
    Martinez-Diaz JL
    Bol Asoc Med P R; 2008; 100(4):55-9. PubMed ID: 19400530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.